Biotech
BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 06/03/13 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to t ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 06/03/13 -- Critical Outcome Technologies Inc. (TSX VENTURE: COT) ("COTI" or the "Corporation") is pleased to announce that it has completed a ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/03/13 -- Med BioGene Inc. (TSX VENTURE: MBI) today announced that its commercial partner, Precision Therapeutics, Inc., presented data regarding Ge ...
TUSTIN, CA: Interim Data Shows 85% Overall Response Rate With 15% Complete Response Rate in HER2-Negative MBC; Final Data From Company's Phase II Pancreatic Cancer Trial Shows Promising Overall Survival Tren ...
TUSTIN, CA: Overall Survival Favors 3 mg/kg Bavituximab Plus Docetaxel Treatment Group Over Control Arm and Across Key Subgroups Analyzed; Data Support Global Phase III Registration Trial in Second-Line Non-Small ...
HALIFAX, NOVA SCOTIA: Immune responses consistent with those required for cancer vaccines to potentially impact disease progression; adds to growing excitement in field of cancer immunotherapy Poster is one of few selected ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 06/03/13 -- MethylGene Inc. (TSX: MYG) today announced that clinical data for mocetinostat, the spectrum selective histone deacetylase (HDAC) inhibitor, was pres ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 06/03/13 -- Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application ( ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 06/03/13 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that develops and commercializes innovative supportive care products, today ann ...
TOKYO and SAN FRANCISCO, CA: TOKYO and SAN FRANCISCO, CA -- (Marketwired) -- 06/03/13 -- Astellas Pharma Inc. (TSE: 4503) and Medivation, Inc. (NASDAQ: MDVN) today announced that after a priority review, Health Canada has approv ...
PARIS: Nanobiotix's NBTXR3 Achieves Clinical Milestone Reaching Proof-Of-Concept in Phase I Trial of Soft Tissue Sarcoma ...
SOUTH SAN FRANCISCO, CA: Responses Observed in Patients With Refractory Multiple Myeloma Treated With TH-302 Plus Dexamethasone; Responses Observed in Patients With Renal Cell Carcinoma and Gastrointestinal Stromal Tumors Tre ...
DANBURY, CT: DANBURY, CT -- (Marketwired) -- 05/31/13 -- , a leading provider of global relocation services, together with Procter & Gamble were awarded the APAC Customer Relationship of the Year award for th ...
OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwired) -- 05/31/13 -- This document corrects and replaces the media advisory that was sent today at 10:28 AM EDT. The following sentence has been added: "Off-site media ...
OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwired) -- 05/31/13 -- The Honourable Gary Goodyear, Minister of State (Science and Technology), will make an important announcement related to applied genomics research. Mi ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/31/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that Mr. Mark Beaudet, interim President & CEO ...
CARLSBAD, CA: CARLSBAD, CA -- (Marketwired) -- 05/30/13 -- International Stem Cell Corporation (OTCQB: ISCO) () a California-based biotechnology company developing novel stem cell based therapies, announced today ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/30/13 -- Med BioGene Inc. (TSX VENTURE: MBI) today reported its financial results for the three months ended March 31, 2013 (all amounts are in Uni ...
HALIFAX, NOVA SCOTIA: IMV's vaccine targets survivin peptides present on most Glioblastoma (Brain Cancer) cells Patients to receive DPX-Survivac in combination with immune modulating drug in effort to extend remission ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/30/13 -- MethylGene Inc. (TSX: MYG) today announced that Charles Baum, MD, PhD, President and Chief Executive Officer, will present an overview of the Company ...
